N-(8-(3-Ethynylphenoxy)octyl-1-deoxynojirimycin suppresses growth and migration of human lung cancer cells

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

28 Citations (Scopus)

Abstract

Previously N-(8-(3-ethynylphenoxy)octyl-1-deoxynojirimycin 1 has been shown to display properties associated with inhibition of angiogenesis. Here we examined the anti-tumourigenic role of 1 in a lung cancer cell line. This agent altered cell surface oligosaccharide expression and inhibited the growth of A549 cells by inducing G1 phase cell cycle arrest and apoptosis. Furthermore, stress fibre assembly and cell migration in A549 cells was markedly suppressed by 1.

Original languageEnglish
Pages (from-to)7540-7543
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume20
Issue number24
DOIs
Publication statusPublished - 15 Dec 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Apoptosis
  • Cell cycle
  • Lung cancer
  • Migration
  • N-(8-(3-Ethynylphenoxy)octyl-1-deoxynojirimycin
  • Stress fibre

Fingerprint

Dive into the research topics of 'N-(8-(3-Ethynylphenoxy)octyl-1-deoxynojirimycin suppresses growth and migration of human lung cancer cells'. Together they form a unique fingerprint.

Cite this